![Michael Biega](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Biega
Investor Relations Contact chez
HARROW, INC.
Profil
Michael Biega is currently VP-Investor Relations & Communications at Harrow, Inc. since 2025.
Formerly, Mr. Biega was Managing Director at Solebury Strategic Communications LLC and Senior Director-Investor Relations at Sensei Biotherapeutics, Inc.
Postes actifs de Michael Biega
| Sociétés | Poste | Début |
|---|---|---|
| HARROW, INC. | Investor Relations Contact | 18/06/2025 |
Anciens postes connus de Michael Biega
| Sociétés | Poste | Fin |
|---|---|---|
Solebury Strategic Communications LLC
 Solebury Strategic Communications LLC Miscellaneous Commercial ServicesCommercial Services Provides investor relations and corporate communications services | Corporate Officer/Principal | - |
| FAETH THERAPEUTICS, INC. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Harrow, Inc.
 Harrow, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development, production, and sale of innovative medications | Health Technology |
Solebury Strategic Communications LLC
Solebury Strategic Communications LLC Miscellaneous Commercial ServicesCommercial Services Provides investor relations and corporate communications services | Commercial Services |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
